drugset / Trial / NCT02878863
Paeoniflorin Combination of Hepatoprotective Drugs Versus Hepatoprotective Drugs Only for Auto-immune Hepatitis
RandomizedParallel-groupOpen-labelTreatment
Summary
An open-label,prospective, randomized pilot study to evaluate the efficacy, safety and tolerability of paeoniflorin, for the treatment of autoimmune hepatitis (AIH) with mild necroinflammatory activity on liver biopsy.
Timeline
- Start
- 2016-08
- Primary completion
- 2017-03
- Completion
- 2017-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Paeoniflorin | Small molecule | 600 mg | — |
| Background | Choline | Other / unclassified | — | — |
| Background | Silymarin | Traditional medicine (herbal / TCM) | — | — |